← Back to catalogue

ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 8

EUDAMED

Class IIa (EU MDR)

Ref 4006-8Model ULTRAMED ENDOTRACHEAL TUBE ORAL/NASALModel ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 8

by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E)

Identity

Trade Name
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 8 EUDAMED
Device Name
ULTRAMED ENDOTRACHEAL TUBE EUDAMED
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED EUDAMED
Model / Reference
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL EUDAMED
4006-8 EUDAMED
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 8 EUDAMED

Identifiers

Primary DI / UDI-DI
06223004251153 EUDAMED
Basic UDI-DI
622300425ETT4005WV EUDAMED
B-06223004251153 EUDAMED
EMDN Code
R01030201 ENDOTRACHEAL TUBES, CUFFED, NOT REINFORCED EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Bulgaria EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Category: Basic endotracheal tube, single-use

ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 8 by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E) — Class IIa — MDR, MDD — listed in EUDAMED

Similar devices

Also classified as Basic endotracheal tube, single-use.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
EG-MF-000038562
Authorised Representative
Obelis s.a. BE-AR-000000106

Sources (2)

  • EUDAMED c148cb74-cc07-4873-a30f-707bc243cfab 61 fields · synced Oct 9, 2026
  • EUDAMED 94ce4873-c110-4afb-b839-0785476fbb66 61 fields · synced May 16, 2026